Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of TAF-EM vs Descovy Under Fasting in Healthy Adults
TCTR20220331002Phase 1Not yet recruiting
- Sponsor
- Government Pharmaceutical Organization
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of tenofovir alafenamide in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Government Pharmaceutical Organization. Planned start May 2022; status: not yet recruiting.
02
Drugs
tenofovir alafenamide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on TCTR20220331002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220331002.